| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.42 | 2e-34 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-18 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-18 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-18 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-17 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-16 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-15 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.36 | 7e-14 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-14 |